Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
3 min read
KalVista Seeks FDA Approval for Sebetralstat, First Oral Treatment for Hereditary Angioedema
21 June 2024
KalVista Submits New Drug Application to FDA for Sebetralstat, the First Oral On-demand Treatment for Hereditary Angioedema.
Read →
Drug Insights
4 min read
Is Pretomanid approved by the FDA?
21 June 2024
The U.S. Food and Drug Administration (FDA) granted approval for Pretomanid on August 14, 2019.
Read →
Latest Hotspot
3 min read
Update on Phase III CAPItello-290 Study: Truqap and Chemotherapy for Advanced Triple-Negative Breast Cancer
21 June 2024
Update on the CAPItello-290 Phase III study of Truqap combined with chemotherapy for advanced or metastatic triple-negative breast cancer.
Read →
Drug Insights
4 min read
Is Pexidartinib approved by the FDA?
21 June 2024
The U.S. Food and Drug Administration (FDA) approved Pexidartinib on August 2, 2019.
Read →
Latest Hotspot
4 min read
FDA Approves NMD Pharma's Phase 2 Trial of NMD670 for Charcot-Marie-Tooth Disease in US
21 June 2024
NMD Pharma Gets FDA IND Approval to Start Phase 2 Study of NMD670 in US for Charcot-Marie-Tooth Disease.
Read →
Drug Insights
3 min read
Is Darolutamide approved by the FDA?
21 June 2024
The U.S. Food and Drug Administration (FDA) approved Darolutamide, marketed under the brand name Nubeqa, on July 30, 2019.
Read →
Latest Hotspot
3 min read
Mozart Therapeutics Begins Phase 1 Trial of MTX-101 for Autoimmune Treatment
21 June 2024
Mozart Therapeutics Administers Initial Dose in Phase 1 Clinical Study of MTX-101 for Autoimmune Disease Therapy.
Read →
Drug Insights
3 min read
Is Recarbrio approved by the FDA?
21 June 2024
The U.S. Food and Drug Administration (FDA) approved Recarbrio, which is a combination of imipenem, cilastatin, and relebactam, on July 16, 2019.
Read →
Latest Hotspot
3 min read
FDA Approves Zymeworks' ZW171, a New Bispecific Antibody for Mesothelin-related Tumors
21 June 2024
Zymeworks Receives FDA Approval for ZW171, a New Bispecific Antibody Targeting Mesothelin-related Tumors.
Read →
Drug Insights
3 min read
Is Amlodipine approved by the FDA?
21 June 2024
The U.S. Food and Drug Administration (FDA) approved amlodipine, which is marketed under brand names such as Norvasc, Katerzia, and Norliqva, for medical use. This approval was granted on July 8, 2019.
Read →
Latest Hotspot
3 min read
iTeos and GSK Initiate Phase 3 GALAXIES Lung-301 Trial for Advanced Lung Cancer Treatment
21 June 2024
iTeos and GSK Launch Phase 3 GALAXIES Lung-301 Trial, Evaluating Belrestotug and Dostarlimab in Untreated, Inoperable Advanced/Metastatic PD-L1 Positive Non-Small Cell Lung Cancer.
Read →
Drug Insights
3 min read
Is Selinexor approved by the FDA?
21 June 2024
The U.S. Food and Drug Administration (FDA) granted approval for selinexor on an accelerated basis on July 3, 2019.
Read →
<
1
<<
96
97
98
99
100
>>
346
>